Press release
Lawsuit filed for Investors in shares of Fluidigm Corporation (NASDAQ: FLDM)

A lawsuit was filed on behalf of investors in Fluidigm Corporation (NASDAQ: FLDM) shares over alleged securities laws violations.
Investors who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) have certain options and for certain investors are short and strict deadlines running. Deadline: November 20, 2020. NASDAQ: FLDM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 1, 2019, Fluidigm Corporation reported second quarter 2019 revenue of $28.2 million, well below analysts’ expectations of $32 million, citing weakness in its microfluidics segment.
Then, on November 5, 2019, after the market closed, Fluidigm Corporation reported that third quarter 2019 revenue declined 8.5% year-over-year primarily due to mass cytometry instrument sales.
Shares of Fluidigm Corporation (NASDAQ: FLDM) declined from $14.50 per share in March 2019 to as low as $2.31 per share on November 8, 2019.
The plaintiff claims that between February 7, 2019 and November 5, 2019, the Defendants failed to disclose to investors that Fluidigm was experiencing longer sales cycles that, as a result, Fluidigm’s revenue was reasonably likely to decline, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) have certain options and should contact the Shareholders Foundation.
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors in shares of Fluidigm Corporation (NASDAQ: FLDM) here
News-ID: 2148744 • Views: …
More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…

Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…

Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…

Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
More Releases for Fluidigm
Spatial OMICS Market Is Booming So Rapidly | Fluidigm, Vizgen PerkinElmer
According to USD Analytics the Global Spatial OMICS Market is projected to register a 11.5% CAGR from 2025 to 2034.
The latest study released on the Global Spatial OMICS Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Spatial OMICS market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access…
Lab-on-a-Chip Market Is Booming So Rapidly | PerkinElmer, Fluidigm, Micronit
The Global Lab-on-a-Chip Market Size is estimated at $7.9 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.4% to reach $16.3 Billion by 2034.
The latest study released on the Global Lab-on-a-Chip Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Lab-on-a-Chip market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry…
Capillary Electrophoresis Market Is Booming So Rapidly | Flottweg, Repligen, Flu …
The latest study released on the Global Capillary Electrophoresis Market by USD Analytics Market Research evaluates market size, trend, and forecast to 2030. The Capillary Electrophoresis market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key…
Biochips Market SWOT Analysis by Leading Key Players: Perkinelmer, Fluidigm, Agi …
Latest research study released on the Global Biochips Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Biochips market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
The global Biochips market…
Biochips Market to See Competition Rise | Perkinelmer, Fluidigm, Agilent Technol …
HTF Market Intelligence published a new research publication on Biochips Market Insights, to 2028" with 150+pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Biochips market was mainly driven by the increasing R&D spending across the world, however latest scenario and economic slowdown have changed complete…
Real Time PCR Kit Market Still Going Strong | Fluidigm, Takara Bio, Danaher, Flu …
Real-time PCR helps in simultaneous amplification and detection of nucleic acids by the help of polymerase chain reaction (PCR). qPCR is a versatile technique which supports various research applications. Real-time PCR delivers sensitivity, specificity, and a wide dynamic range for detecting target nucleic acids. It is becoming a powerful technology for research applications which is able to cover the spectrum of biology from basic research to translational medicine to applied…